Boston Scientific BSX Balance Sheet Statement
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| $850M+146% | $965M+165% | $893M+11.2% | $388M-51.1% | $345M-10.2% | ||
| $3.15B+12.4% | $3.06B+14.7% | $2.96B+13.4% | $2.93B+16.8% | $2.81B+16.3% | ||
| $3.12B+8.7% | $2.94B+4.7% | $2.92B+6.1% | $2.86B+9.7% | $2.87B+11.9% | ||
| $8.68B+18.4% | $8.79B+27.1% | $8.04B-8.3% | $7.12B-20.8% | $7.34B-10.4% | ||
| $4.06B+19.9% | $4.04B+22.5% | $3.8B+23.5% | $3.46B+17.3% | $3.39B+17.0% | ||
| $18.54B+6.9% | $18.28B+7.0% | $18.21B+21.2% | $18.08B+25.6% | $17.34B+20.7% | ||
| $44.35B+10.5% | $43.67B+10.9% | $42.71B+12.2% | $41.56B+12.0% | $40.14B+9.5% | ||
| $1.14B+13.6% | $1.14B+19.2% | $1B+10.5% | $962M+6.2% | $1B+9.0% | ||
| $4.57B-9.6% | $5.44B-15.0% | $5.33B-9.8% | $5.19B-6.9% | $5.06B+2.9% | ||
| —— | —— | —— | —— | —— | ||
| $6.91B+107% | $5.57B+108% | $4.9B+133% | $4.14B+153% | $3.35B+155% | ||
| $25.86B+16.4% | $24.23B+11.3% | $23.39B+13.0% | $22.42B+10.0% | $22.21B+11.5% | ||
| $44.35B+10.5% | $43.67B+10.9% | $42.71B+12.2% | $41.56B+12.0% | $40.14B+9.5% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are Boston Scientific's total assets?
- Boston Scientific (BSX) holds $44.4B in total assets, up 10.5% year over year.
- How much cash does Boston Scientific have?
- Boston Scientific holds $850.0M in cash and equivalents.
- Can Boston Scientific cover its short-term obligations?
- Its current ratio is 1.90 — current assets exceed current liabilities.
- Where does Boston Scientific's balance sheet data come from?
- Every line is extracted from Boston Scientific's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
